PageOverview.com
 

Websites, domains, hosts that links to novonordiskpro.com

Our database shows, that the website novonordiskpro.com is linked by a total of 9 websites.

 
Number of websites/domains displayed: 9
Results found: 9
 

Websites discovered:

Rethink Obesity® | HCP Support Website
http://pageoverview.com/website-report/rethinkobesity.com
Discover the science behind obesity and get tools to support weight management. Visit the HCP support website and learn how obesity may influence your patients.
  • Expected expiration: February 6th in 2019
  • Creation date: February 6th in 2014
  • Renew date: February 16th in 2016
  • Google Analytics: 44074826-6
Xultophy® 100/3.6 (insulin degludec and liraglutide injection) 100 u/mL and 3.6 mg/mL | HCP Website
http://pageoverview.com/website-report/xultophy10036pro.com
Learn about Xultophy® 100/3.6, basal insulin & GLP-1 in one injection. Read Important Safety Information & Prescribing Information, including Boxed Warning.
  • Expected expiration: September 26th in 2018
  • Creation date: September 26th in 2016
  • Renew date: September 26th in 2016
  • Google Analytics: 44074826-91
Fiasp® Fast-Acting Insulin | Fiasp® (insulin aspart injection) 100 U/mL
http://pageoverview.com/website-report/fiasppro.com
Fiasp® is a fast-acting insulin aspart indicated to improve glycemic control in adults with type 1 or type 2 diabetes. Read important safety & prescribing info on this page.
  • Expected expiration: December 20th in 2018
  • Creation date: December 20th in 2016
  • Renew date: December 20th in 2016
  • Google Analytics: 44074826-94
  • AddThis User: ra-57d08e7d95e26a45
Novo Nordisk Mexico
http://pageoverview.com/website-report/novonordisk.com.mx
  • Expected expiration: September 17th in 2019
  • Creation date: September 18th in 2002
  • Renew date: February 27th in 2018
  • Google Plus Account: +novonordisk
NovoLog® (insulin aspart injection) 100 U/mL HCP Website
http://pageoverview.com/website-report/novologpro.com
View the official health care professionals website with clinical trial information and resources on NovoLog®.
  • Expected expiration: October 28th in 2018
  • Creation date: October 28th in 2010
  • Renew date: November 1st in 2016
  • Google Analytics: 44074826-3
Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL) HCP Website
http://pageoverview.com/website-report/tresibapro.com
Try our once-daily, long-acting insulin to improve glycemic control in pediatric & adult patients with diabetes. Read Important Safety & Prescribing Info.
  • Expected expiration: February 14th in 2019
  • Creation date: February 14th in 2012
  • Renew date: February 17th in 2017
  • Google Analytics: 44074826-83
Diabetes Resources & Patient Care for Health Care Professionals | NovoMedLink
http://pageoverview.com/website-report/novomedlink.com
US health care professionals can get Novo Nordisk product information and videos, product samples, patient education materials and formulary coverage data.
  • Expected expiration: March 27th in 2019
  • Creation date: March 27th in 2003
  • Renew date: February 16th in 2016
  • Google Analytics: 44074826-1
Levemir® (insulin detemir [rDNA origin] injection) HCP Website
http://pageoverview.com/website-report/levemirpro.com
See information about basal insulin & the long-acting insulin from Levemir®. Read Important Safety & Prescribing Info from the Levemir® HCP Website.
  • Expected expiration: October 28th in 2018
  • Creation date: October 28th in 2010
  • Renew date: November 1st in 2016
  • Google Analytics: 44074826-2
GLP-1 RA Therapy for T2D | Ozempic® (semaglutide) injection 0.5 mg or 1 mg
http://pageoverview.com/website-report/ozempicpro.com
Once weekly Ozempic® for Type 2 diabetes is now available in pharmacies. See Full Prescribing and Safety Information including Boxed Warning.
  • Expected expiration: October 3rd in 2018
  • Creation date: October 3rd in 2016
  • Renew date: September 22nd in 2017
0.0109 // 2024-05-04 09:36:35
All Rights reserved 2018 © PageOverview.com